Eiger BioPharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Palo Alto, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Eiger BioPharmaceuticals, Inc. has filed 694 SEC EDGAR filings since 05 Oct 2004

SEC filing history

Showing 201-225 of 687 matching filings.

Per page
25
Current page
9
4

FORM 4 SUBMISSION

Filing date
12 Aug 2020
Reporting date
11 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-235655

PROSPECTUS SUPPLEMENT FILED PURSUANT TO RULE 424(B)(5)

Filing date
06 Aug 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

FORM 8-K

Filing date
06 Aug 2020
Reporting date
06 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

8-K

Filing date
17 Jun 2020
Reporting date
15 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36183

DEFA14A

Filing date
29 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

8-K

Filing date
19 May 2020
Reporting date
19 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

8-K

Filing date
07 May 2020
Reporting date
07 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36183

DEFA14A

Filing date
28 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36183

DEF 14A

Filing date
28 Apr 2020
Reporting date
10 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

8-K

Filing date
01 Apr 2020
Reporting date
01 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

8-K

Filing date
23 Mar 2020
Reporting date
23 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Mar 2020
Reporting date
16 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Mar 2020
Reporting date
16 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Mar 2020
Reporting date
12 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Mar 2020
Reporting date
12 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Mar 2020
Reporting date
12 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Mar 2020
Reporting date
12 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Mar 2020
Reporting date
12 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Mar 2020
Reporting date
12 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .